Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis.
Kirchmair R, Egger M, Walter DH, Eisterer W, Niederwanger A, Woell E, Nagl M, Pedrini M, Murayama T, Frauscher S, Hanley A, Silver M, Brodmann M, Sturm W, Fischer-Colbrie R, Losordo DW, Patsch JR, Schratzberger P. Kirchmair R, et al. Among authors: hanley a. Circulation. 2004 Aug 31;110(9):1121-7. doi: 10.1161/01.CIR.0000139884.81390.56. Epub 2004 Aug 23. Circulation. 2004. PMID: 15326074
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo.
Kirchmair R, Gander R, Egger M, Hanley A, Silver M, Ritsch A, Murayama T, Kaneider N, Sturm W, Kearny M, Fischer-Colbrie R, Kircher B, Gaenzer H, Wiedermann CJ, Ropper AH, Losordo DW, Patsch JR, Schratzberger P. Kirchmair R, et al. Among authors: hanley a. Circulation. 2004 Feb 17;109(6):777-83. doi: 10.1161/01.CIR.0000112574.07422.C1. Circulation. 2004. PMID: 14970115
Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia.
Kawamoto A, Murayama T, Kusano K, Ii M, Tkebuchava T, Shintani S, Iwakura A, Johnson I, von Samson P, Hanley A, Gavin M, Curry C, Silver M, Ma H, Kearney M, Losordo DW. Kawamoto A, et al. Among authors: hanley a. Circulation. 2004 Sep 14;110(11):1398-405. doi: 10.1161/01.CIR.0000141563.71410.64. Epub 2004 Aug 30. Circulation. 2004. PMID: 15337699
Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW. Yoon YS, et al. Among authors: hanley a. Circulation. 2005 Apr 26;111(16):2073-85. doi: 10.1161/01.CIR.0000162472.52990.36. Circulation. 2005. PMID: 15851615
Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW. Iwakura A, et al. Among authors: hanley a. Circulation. 2003 Dec 23;108(25):3115-21. doi: 10.1161/01.CIR.0000106906.56972.83. Epub 2003 Dec 15. Circulation. 2003. PMID: 14676142
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.
Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, Tietz AB, Kirchmair R, Silver M, Curry C, Wecker A, Yoon YS, Heidenreich R, Hanley A, Kearney M, Tio FO, Kuenzler P, Isner JM, Losordo DW. Walter DH, et al. Among authors: hanley a. Circulation. 2004 Jul 6;110(1):36-45. doi: 10.1161/01.CIR.0000133324.38115.0A. Epub 2004 Jun 21. Circulation. 2004. PMID: 15210598
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia.
Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T. Kawamoto A, et al. Among authors: hanley a. Circulation. 2003 Jan 28;107(3):461-8. doi: 10.1161/01.cir.0000046450.89986.50. Circulation. 2003. PMID: 12551872
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.
Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW. Kawamoto A, et al. Among authors: hanley a. Circulation. 2006 Nov 14;114(20):2163-9. doi: 10.1161/CIRCULATIONAHA.106.644518. Epub 2006 Oct 30. Circulation. 2006. PMID: 17075009
Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth.
Goukassian DA, Kishore R, Krasinski K, Dolan C, Luedemann C, Yoon YS, Kearney M, Hanley A, Ma H, Asahara T, Isner JM, Losordo DW. Goukassian DA, et al. Among authors: hanley a. Circ Res. 2003 Jul 25;93(2):162-9. doi: 10.1161/01.RES.0000082980.94211.3A. Epub 2003 Jun 26. Circ Res. 2003. PMID: 12829616
527 results